Isovue Injection, Solution
Product Images NDC 0270-1315

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isovue (NDC 0270-1315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ce50f02-lab-iso-250-10x100 (Ce50f02 Lab Iso 250 10x100)

ISOVUE-250 (Iopamidol Injection 51%) packaging label from Bracco Diagnostics Inc. The label indicates a box containing 10 bottles, each with 100 mL. It specifies 25% organically bound iodine and highlights use restrictions, including 'FOR INTRAVASCULAR USE ONLY' and 'Rx only.' Additional information includes manufacturing details and storage instructions.*

FDA Label Image

Ce51902-lab-iso-300-10x100 (Ce51902 Lab Iso 300 10x100)

Packaging label for ISOVUE-300 30% Organically Bound Iodine (Iopamidol Injection 61%) by Bracco Diagnostics Inc. Contains 10 bottles of 100 mL each. Label includes warnings for intravascular use only and not for intrathecal use, with dosage and storage instructions. Barcode and lot/expiration placeholders are visible.*

FDA Label Image

Ci9f504-lab-iso-200-200ml (Ci9f504 Lab Iso 200 200ml)

ISOVUE-200 41% Iopamidol Injection 200 mL single-dose bottle label by Bracco Diagnostics Inc. The label states 20% organically bound iodine, RX only, and highlights it is not for intrathecal use. Storage instructions and product contents including 408 mg iopamidol per mL are present, along with manufacturer information.*

FDA Label Image

Isovue-370 75ml Bottle (Isovue 370 75ml Bottle)

Label for ISOVUE-370 (Iopamidol Injection 76%) 75 mL single dose bottle by Bracco Diagnostics Inc, containing 37% organically bound iodine. The label states it is for intravascular use only, not for intrathecal use, with storage instructions and manufacturer information including Bracco Diagnostics Inc., Monroe Twp, NJ, and BIPSO GmbH, Germany.*

FDA Label Image

Isovue Structure (Isovue Struct)

Chemical structure diagram of the active ingredient in ISOVUE 300, showing iodine atoms attached to a benzene ring along with side chains containing hydroxyl and amide groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.